Back to Search
Start Over
Allogeneic Kidney Transplantation After COVID-19: A Case Report
- Source :
- Transplantation Proceedings
- Publication Year :
- 2021
-
Abstract
- Background Patients undergoing organ transplantation are immunosuppressed and already at risk of various diseases. We report about a patient who underwent ABO-incompatible kidney transplantation after coronavirus disease 2019 (COVID-19) without a recurrence of infection. Case report A 68-year-old woman presented with end-stage renal failure owing to primary autosomal dominant polycystic kidney disease; accordingly, hemodialysis was initiated in September 2020. Her medical history included bilateral osteoarthritis, lumbar spinal stenosis, hypertension, and hyperuricemia. In mid-January 2021, she contracted severe acute respiratory syndrome coronavirus 2 infection from her husband. Both of them were hospitalized and received conservative treatment. Because their symptoms were mild, they were discharged after 10 days. The patient subsequently underwent ABO-incompatible kidney transplantation from her husband who recovered from COVID-19 in March 2021. Before kidney transplantation, her COVID-19 polymerase chain reaction test was negative, confirming the absence of pre-existing COVID-19 immediately before the procedure. Computed tomography revealed no pneumonia. Initial immunosuppression was induced by administering tacrolimus, mycophenolate mofetil, methylprednisolone, basiliximab, rituximab, and 30 g of intravenous immunoglobulin. Double-filtration plasmapheresis and plasma exchange were performed once before ABO-incompatible kidney transplantation. The renal allograft functioned immediately, and the postoperative course was normal without rejection. COVID-19 did not recur. In addition, her serum creatinine levels and renal function had otherwise remained stable. Conclusion Living kidney transplantation was safely performed in a patient with COVID-19 without postoperative complications or rejection. During the COVID-19 pandemic, the possibility of severe acute respiratory syndrome coronavirus 2 infection during transplantation surgery must be considered.
- Subjects :
- Graft Rejection
medicine.medical_specialty
Basiliximab
medicine.medical_treatment
Autosomal dominant polycystic kidney disease
Renal function
Kidney
Methylprednisolone
Article
Organ transplantation
Tacrolimus
SARS-CoV2, severe acute respiratory syndrome coronavirus 2
ABO Blood-Group System
PCR, polymerase chain reaction
medicine
Humans
Pandemics
COVID-19, coronavirus disease
Kidney transplantation
Aged
Transplantation
business.industry
Hematopoietic Stem Cell Transplantation
COVID-19
Immunoglobulins, Intravenous
immunesuppression
Immunosuppression
Mycophenolic Acid
medicine.disease
Kidney Transplantation
Surgery
Blood Group Incompatibility
Creatinine
Female
Hemodialysis
business
Rituximab
Immunosuppressive Agents
medicine.drug
Subjects
Details
- ISSN :
- 18732623
- Volume :
- 54
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Transplantation proceedings
- Accession number :
- edsair.doi.dedup.....abdc55fb2b7efaba6a9a9ba34ec5e575